Vertex reports results from Phase IIb AMPLIFIED trial for AMKD

Vertex Pharmaceuticals has reported positive data from its Phase IIb AMPLIFIED trial evaluating inaxaplin in individuals with AMKD. The post Vertex reports results from Phase IIb AMPLIFIED trial for AMKD appeared first on Clinical Trials Ar…

Summary from Clinical Trials Arena.

Coverage 1 article · 1 outlet

1. Clinical Trials Arena yesterday
   Vertex reports results from Phase IIb AMPLIFIED trial for AMKD ↗